Session Information
2010 Midyear Clinical Meeting
Click here to go to the previous page
Managing Anticoagulation Therapy: An Advanced Workshop for Pharmacists 2010
Track: Pre-Meeting Workshops (CE)
Program Code: 353-L01
Date: Sunday, December 5, 2010
Time: 8:30 AM to 4:30 PM EST
Location: Room 205A, Level 2
PRESENTER(S):   Click the plus sign to see more detailed information about each speaker.
 William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
John Fanikos
 Michael Gulseth, Program Director for Anticoagulation Services, Sanford USD Medical Center
Dr. Edith Nutescu, PharmD, FCCP, Clinical Associate Professor and Director, Antithrombosis Center, University of Illinois at Chicago, College of Pharmacy
 Maureen Smythe, PharmD, FCCP, Professor, Department of Pharmacy Practice, Wayne State University
 Ann Wittkowsky, PharmD, CACP, Director, Anticoagulation Services, University of Washington Medical Center
PROGRAM CHAIR:   Click the plus sign to see more detailed information about each speaker.
 William Dager, PharmD, FCSHP, Pharmacist Specialist, University of California, Davis Medical Center
Description
Workshop Fee: $210
Pre-registration is required; Registration must received on or before November 22.
Registration is limited to 60 participants. Lunch is on your own.
The National Patient Safety Goals on anticoagulation have generated new opportunities for pharmacists to develop professionally in this area. Designed for pharmacists who already have some experience in managing anticoagulation therapy, this advanced workshop employs a case-based approach to developing and implementing safe, effective management plans.

LEARNER OUTCOMES:
  • Describe approaches to documenting and supporting continued activities related to managing anticoagulation therapy.
  • Describe approaches to switching between, overlapping, holding, or reversing anticoagulants.
  • Develop and communicate an anticoagulant management plan.
  • Discuss approaches to establishing and revising protocols for anticoagulation therapy.
  • Identify situations potentially predisposing patients to adverse anticoagulation related events and discuss approaches to initiating and monitoring anticoagulant therapy.


No items are available for this session.